Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.
UNLABELLED: This analysis was conducted to assess the effect of high versus lower doses of ibandronate on nonvertebral fractures. The results were adjusted for clinical fracture, age, and bone density. The treatment effect was dose-dependent. Higher doses of ibandronate significantly reduced the ris...
Main Authors: | Cranney, A, Wells, G, Yetisir, E, Adami, S, Cooper, C, Delmas, P, Miller, P, Papapoulos, S, Reginster, J, Sambrook, P, Silverman, S, Siris, E, Adachi, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
by: Evgeni Germanovich Zotkin
Published: (2010-06-01) -
EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
by: Evgeni Germanovich Zotkin
Published: (2010-06-01) -
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
by: Jonathan D. Adachi, et al.
Published: (2017-04-01) -
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
by: Reginster, J, et al.
Published: (2006) -
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.
by: Reginster, J, et al.
Published: (2006)